Class information for:
Level 1: TUMOR IMMUNOL BIOL//SIPULEUCEL T//PROSTVAC

Basic class information
Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
10 4 IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY 1369268
17 3       IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL 124793
201 2             IMMUNOTHERAPY//DENDRITIC CELLS//MYELOID DERIVED SUPPRESSOR CELLS 20719
11302 1                   TUMOR IMMUNOL BIOL//SIPULEUCEL T//PROSTVAC 1020

Terms with highest relevance score


rank Category termType chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 TUMOR IMMUNOL BIOL address 2050754 18% 36% 182
2 SIPULEUCEL T authKW 524848 4% 45% 38
3 PROSTVAC authKW 168215 1% 78% 7
4 TRICOM authKW 137628 1% 64% 7
5 PROSTVAC VF authKW 128737 0% 83% 5
6 THERAPEUTIC CANCER VACCINE authKW 120233 1% 32% 12
7 IMMUNOTHERAPY authKW 117289 22% 2% 228
8 IMMUNOGENIC MODULATION authKW 111225 1% 60% 6
9 CANCER VACCINE authKW 111099 7% 5% 67
10 RECOMBINANT VACCINE GRP address 98870 0% 80% 4

Web of Science journal categories


chi_square_rank Category chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 Oncology 10679 53% 0% 540
2 Immunology 3079 27% 0% 276
3 Urology & Nephrology 1942 13% 0% 135
4 Medicine, Research & Experimental 1322 14% 0% 147
5 Biotechnology & Applied Microbiology 266 8% 0% 84
6 Endocrinology & Metabolism 97 5% 0% 51
7 Radiology, Nuclear Medicine & Medical Imaging 46 4% 0% 40
8 Genetics & Heredity 24 4% 0% 36
9 Hematology 13 2% 0% 20
10 Biology 11 2% 0% 17

Address terms


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 TUMOR IMMUNOL BIOL 2050754 18% 36% 182
2 RECOMBINANT VACCINE GRP 98870 0% 80% 4
3 CLIN IMMUNOTHER Y GRP 85821 0% 56% 5
4 JR GRP VIROL IMMUNOL 82390 0% 67% 4
5 SECT PHARMACOL MED ONCOL 64364 0% 42% 5
6 LIFE UNIV CLIN GROSSHADERN 61795 0% 100% 2
7 MED ONCOL BRANCH 44680 3% 4% 33
8 GENITOURINARY MALIGNANCIES BRANCH 32486 1% 12% 9
9 ONYVAX LTD 32177 0% 21% 5
10 ADVAXIS INC 30897 0% 100% 1

Journals


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 CANCER IMMUNOLOGY IMMUNOTHERAPY 27589 6% 1% 63
2 PROSTATE 13448 4% 1% 45
3 CLINICAL CANCER RESEARCH 9844 7% 0% 70
4 EXPERT REVIEW OF VACCINES 9468 2% 2% 20
5 CURRENT OPINION IN MOLECULAR THERAPEUTICS 7934 1% 2% 15
6 ONCOIMMUNOLOGY 5922 1% 1% 15
7 IMMUNOTHERAPY 5710 1% 2% 12
8 JOURNAL OF IMMUNOTHERAPY 4048 1% 1% 15
9 CLINICAL GENITOURINARY CANCER 3916 1% 1% 10
10 CANCER IMMUNOLOGY RESEARCH 3869 1% 2% 8

Author Key Words


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass LCSH search Wikipedia search
1 SIPULEUCEL T 524848 4% 45% 38 Search SIPULEUCEL+T Search SIPULEUCEL+T
2 PROSTVAC 168215 1% 78% 7 Search PROSTVAC Search PROSTVAC
3 TRICOM 137628 1% 64% 7 Search TRICOM Search TRICOM
4 PROSTVAC VF 128737 0% 83% 5 Search PROSTVAC+VF Search PROSTVAC+VF
5 THERAPEUTIC CANCER VACCINE 120233 1% 32% 12 Search THERAPEUTIC+CANCER+VACCINE Search THERAPEUTIC+CANCER+VACCINE
6 IMMUNOTHERAPY 117289 22% 2% 228 Search IMMUNOTHERAPY Search IMMUNOTHERAPY
7 IMMUNOGENIC MODULATION 111225 1% 60% 6 Search IMMUNOGENIC+MODULATION Search IMMUNOGENIC+MODULATION
8 CANCER VACCINE 111099 7% 5% 67 Search CANCER+VACCINE Search CANCER+VACCINE
9 GVAX 96245 1% 35% 9 Search GVAX Search GVAX
10 PROSTVAC VF TRICOM 92692 0% 100% 3 Search PROSTVAC+VF+TRICOM Search PROSTVAC+VF+TRICOM

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.

Classes with closest relation at Level 1


rank cluster_id2 link
1 35247 5T4//5T4 ONCOFETAL ANTIGEN//MEDAWAR
2 19238 IMMUNOGENIC CELL DEATH//U1015//U805
3 16938 CANC VACCINE DEV PROGRAM//TUMOR VACCINE GRP//CANC IMMUNOL IMMUNOTHER Y
4 24410 CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE
5 27441 RAS DERIVED PEPTIDES//P53 PEPTIDES//RAS PEPTIDES
6 10158 TUMOR VACCINE//ADV CELL MOL THER Y//ALLOGENEIC VACCINATION
7 2434 CASTRATION RESISTANT PROSTATE CANCER//ENZALUTAMIDE//ABIRATERONE
8 31085 GV1001//UNITE VIROL MOL VECTOROL//VAXON BIOTECH
9 548 DENDRITIC CELLS//IMMUNOTHERAPY//TUMOR LYSATE
10 32894 ANGIOGENET//ASBESTOS RELATED DISEASES//AUSTRALIAN MESOTHELIOMA TUMOUR BANK

Go to start page